Related Experiment Video
Updated: Aug 2, 2026
08:56
Synthesis of 1,2-Azaborines and the Preparation of Their Protein Complexes with T4 Lysozyme Mutants
Published on: March 25, 2017
[Azo derivatives of levorin]
Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology
|January 1, 1986
Summary
Levorin, an antibiotic, was chemically modified using sodium nitrite to create azo compounds. These derived azo levorins exhibited significantly reduced biological activity compared to the original levorin.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Pharmacology
Background:
- Levorin is an aromatic heptaenic antibiotic.
- Antibiotic modification is crucial for developing new therapeutic agents.
- Understanding structure-activity relationships is key in drug development.
Purpose of the Study:
- To synthesize novel azo compounds derived from levorin.
- To investigate the chemical properties and biological activity of these azo levorins.
- To explore the impact of chemical modification on antibiotic efficacy.
Main Methods:
- Levorin reacted with sodium nitrite in acetic acid to form a diazo compound.
- The diazo compound was coupled with beta-napthol or H-acid.
- Physico-chemical characteristics and biological activity of the resulting azo levorins were determined.
Main Results:
- Azo compounds were successfully synthesized from levorin.
- The synthesized azo levorins showed good solubility in organic solvents and aqueous solutions.
- Biological activity of azo levorins was 100-200 times lower than that of the parent levorin.
Conclusions:
- Chemical modification of levorin into azo compounds significantly reduces its antibiotic potency.
- The study presents the physico-chemical characteristics of these novel azo levorin derivatives.
- Further research may explore alternative modifications to retain or enhance levorin's activity.
Related Concept Videos
01:15Carboxylic Acid Derivatives: Overview
Carboxylic acid derivatives are formed by replacing the hydroxyl group of carboxylic acids with a different functional group. The most common carboxylic acid derivatives are:
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.